Literature DB >> 492324

Immunoreactive forms of human erythrocyte ankyrin are present in diverse cells and tissues.

V Bennett.   

Abstract

Ankyrin is a polypeptide of molecular weight (MW) 200,000 which is tightly bound to the cytoplasmic surface of the human erythrocyte membrane and has been identified as the high-affinity membrane attachment protein for spectrin. This protein has also been shown to be associated with band 3 (ref. 4), the major transmembrane protein which links a cytoplasmic structural protein to an integral membrane protein. A water-soluble, 72,000-MW, proteolytic fragment of ankyrin has been purified which retains the ability to bind to spectrin, and competitively inhibits reassociation of spectrin with membranes. Monospecific antibodies directed against this fragment have been prepared and demonstrated to cross-react only with ankyrin among the erythrocyte membrane proteins. The present study reports the use of these antibodies to develop a radioimmunoassay capable of detecting femtomolar quantities of ankyrin, and demonstrates the presence of small but significant amounts of immunoreactivity in a variety of types of cells and tissues.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 492324     DOI: 10.1038/281597a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  33 in total

1.  Analysis of the mobilities of band 3 populations associated with ankyrin protein and junctional complexes in intact murine erythrocytes.

Authors:  Gayani C Kodippili; Jeff Spector; Jacob Hale; Katie Giger; Michael R Hughes; Kelly M McNagny; Connie Birkenmeier; Luanne Peters; Ken Ritchie; Philip S Low
Journal:  J Biol Chem       Date:  2011-12-06       Impact factor: 5.157

2.  Brain membrane protein band 3 performs the same functions as erythrocyte band 3.

Authors:  M M Kay; J Hughes; I Zagon; F B Lin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

3.  Definition of a physiologic aging autoantigen by using synthetic peptides of membrane protein band 3: localization of the active antigenic sites.

Authors:  M M Kay; J J Marchalonis; J Hughes; K Watanabe; S F Schluter
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

4.  Regulation of erythrocyte Na+/K+/2Cl- cotransport by an oxygen-switched kinase cascade.

Authors:  Suilan Zheng; Nathan A Krump; Mary M McKenna; Yen-Hsing Li; Anke Hannemann; Lisa J Garrett; John S Gibson; David M Bodine; Philip S Low
Journal:  J Biol Chem       Date:  2018-12-18       Impact factor: 5.157

5.  Linkage of a membrane skeleton to integral membrane glycoproteins in human platelets. Identification of one of the glycoproteins as glycoprotein Ib.

Authors:  J E Fox
Journal:  J Clin Invest       Date:  1985-10       Impact factor: 14.808

6.  Functional isolation of novel nuclear proteins showing a variety of subnuclear localizations.

Authors:  Kazuki Moriguchi; Tadzunu Suzuki; Yukihiro Ito; Yukiko Yamazaki; Yasuo Niwa; Nori Kurata
Journal:  Plant Cell       Date:  2005-01-19       Impact factor: 11.277

7.  Polypeptides immunologically related to band 3 are present in nucleated somatic cells.

Authors:  M M Kay; C M Tracey; J R Goodman; J C Cone; P S Bassel
Journal:  Proc Natl Acad Sci U S A       Date:  1983-11       Impact factor: 11.205

8.  Goblin (ankyrin) in striated muscle: identification of the potential membrane receptor for erythroid spectrin in muscle cells.

Authors:  W J Nelson; E Lazarides
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Erythrocyte ankyrin: immunoreactive analogues are associated with mitotic structures in cultured cells and with microtubules in brain.

Authors:  V Bennett; J Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

10.  The partitioning of delta 1-tetrahydrocannabinol into erythrocyte membranes in vivo and its effect on membrane fluidity.

Authors:  J T Leuschner; D R Wing; D J Harvey; G A Brent; C E Dempsey; A Watts; W D Paton
Journal:  Experientia       Date:  1984-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.